About 300 reports

Its signs and symptoms include weight loss, fever, hypertension, malaise, night sweats, and blood in the urine.

  • Immunotherapy
  • Argos Therapeutics, Inc.
  • AstraZeneca PLC
  • AVEO Oncology
  • Bristol-Myers Squibb Company
  • Progressive bone marrow failure resulting in a decrease in platelet count; Associated with increased or unexplained bleeding or bruising
  • SHOWS THE SYMPTOMS OF PROGRESSIVE CLL AS DEFINED BY THE INTERNATIONAL WORKSHOP ON CHRONIC LYMPHOCYTIC LEUKEMIA (IWCLL).

GLOBALDATA EPIDEMIOLOGISTS CALCULATED THE ONE-, TWO-, THREE-, AND FOUR-YEAR OBSERVED SURVIVAL PERCENTAGES USING US WEIGHTS FROM 1990-2009.

  • Immunotherapy
  • AbbVie Inc.
  • Celgene Corporation
  • Gilead Sciences, Inc.
  • Roche Group

However, they are associated with a number of side effects such as weight gain and high blood pressure.

  • Immunotherapy
  • AbbVie Inc.
  • Amryt Pharma plc
  • Celgene Corporation
  • Fibrocell Science, Inc.

Persistent cough, shortness of breath, frequent chest infections, coughing up blood, pain or discomfort in the chest and weight loss.

  • Immunotherapy
  • Market Size
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.

AEs of Grade III or higher in the TS-## and UFT/ LV groups were diarrhea, loss of appetite, elevated total bilirubin value, elevated AST, and elevated ALT (Taiho Pharma, press release, January ##, 2013).

  • Immunotherapy
  • Monoclonal Antibody
  • Therapy
  • Market Size
  • Merck & Co., Inc.

PEOPLE SUFFERING FROM UC OFTEN EXPERIENCE LOSS OF APPETITE, FATIGUE, AND WEIGHT LOSS.

  • Immunotherapy
  • AbbVie Inc.
  • Janssen Biotech, Inc.
  • Pfizer Inc.
  • Remicade group

Common symptoms include swollen lymph nodes, itching, night sweats, fatigue, unexplained weight loss, and intermittent fever (Armitage, 2005).

  • Cancer
  • Immunotherapy
  • Lymphoma
  • United States
  • Forecast

Fatigue, fever, and weight loss are also common RA symptoms. ##. ##. ## RHEUMATOID ARTHRITIS Stage one, or early-stage RA, involves initial inflammation in the joint capsule and swelling of synovial tissue.

  • Immunotherapy
  • AbbVie Inc.
  • Eli Lilly & Co.
  • Janssen Biotech, Inc.
  • Johnson & Johnson

Common symptoms include swollen lymph nodes, itching, night sweats, fatigue, unexplained weight loss, and intermittent fever (Armitage, 2005).

  • Cancer
  • Immunotherapy
  • Lymphoma
  • United States
  • Forecast

COMMON SYMPTOMS OF CRC ARE: BLOOD IN STOOL, STOMACH PAINS, ACHES OR CRAMPS THAT DO NOT GO AWAY, WEIGHT LOSS, AND A PERSISTENT CHANGE IN BOWEL HABIT (CDC, 2016; NHS, 2015).

  • Immunotherapy
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Roche Group
  • Taiho Pharmaceutical Co., Ltd.

THIS IN TURN LEADS TO MALABSORPTION OF INGESTED FOOD, MALNUTRITION AND WEIGHT LOSS.

  • Immunotherapy
  • Market Size
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Biologics, Inc.

However, the effect of weight loss on the general risk of cancer among obese patients has been poorly characterized, as only a small proportion of obese people are able to achieve sustained weight loss (Wolin et al., 2010).

  • Immunotherapy
  • Market Size
  • Juno Therapeutics Inc.
  • Merck & Co., Inc.
  • Novartis AG

Metastatic breast cancer has a variety of non-specific symptoms, such as unexplained weight loss, fever, chills, and bone pain.

  • Cancer
  • Immunotherapy
  • AstraZeneca PLC
  • Novartis AG
  • Roche Group

A number of AEs occurred more frequently in the roflumilast treatment groups than in placebo groups, including diarrhea (##-##%), weight loss (##- ##%), and nausea (##%) (Bayer, 2012).

  • Immunotherapy
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline plc
  • Novartis AG

PROFILES OF HEALTH, AUSTRALIA, 2011-## - HEIGHT AND WEIGHT.

  • Immunotherapy
  • Australia
  • Merck & Co., Inc.
  • Novartis AG
  • Roche Group

Less common symptoms include weight loss, rheumatoid nodules and, rarely, inflammation in other organs and tissues, including the eyes, heart and lungs. ##. ## Symptoms Rheumatoid nodules are firm, fleshy, subcutaneous lumps that can appear on the hands, feet and elbows.

  • Immunotherapy
  • Market Size
  • AbbVie Inc.
  • Galapagos NV
  • Pfizer Inc.

However, the effect of weight loss on the general risk of cancer among obese patients has been poorly characterized, as only a small proportion of obese persons are able to achieve sustained weight loss.

  • Immunotherapy
  • AstraZeneca PLC
  • Celgene Corporation
  • Novartis AG
  • Pfizer Inc.

PEOPLE SUFFERING FROM UC OFTEN EXPERIENCE LOSS OF APPETITE, FATIGUE, AND WEIGHT LOSS.

  • Immunotherapy
  • Market Size
  • EA Pharma Co., Ltd.
  • Pfizer Inc.
  • Remicade group

Indirect costs include unemployment, productivity loss, and losses due to disability.

  • Immunotherapy
  • Amgen Inc.
  • Johnson & Johnson
  • Pfizer Inc.
  • Remicade group

Importantly, the combination therapy in mice did not cause any weight loss or gain in the animals - an indication that the drug regimen might be reasonably well-tolerated in humans.

  • Immunotherapy
  • Therapy
  • United States
  • iTeos Therapeutics SA
  • Ludwig Institute For Cancer Research Ltd

The most commonly reported AEs (affecting more than ##% of patients) in the Afinitor arm included stomatitis, rash, fatigue, diarrhea, nausea, decreased appetite, weight loss, and cough.

  • Immunotherapy
  • Market Size
  • Novartis AG
  • Pfizer Inc.
  • Roche Group

Intensification of weight-loss interventions increases based on a child' s response to care.

  • Immunotherapy
  • Infectious Disease
  • Therapy
  • United States
  • Mallinckrodt plc

GLOBALDATA ASSUMES AVERAGE COUNTRY-SPECIFIC WEIGHTS FOR A ##:## RATIO OF WOMEN TO MEN.

  • Immunotherapy
  • World
  • Market Size
  • AstraZeneca PLC
  • Merck & Co., Inc.

FATIGUE, FEVER, AND WEIGHT LOSS ARE ALSO COMMON RA SYMPTOMS.

  • Immunotherapy
  • AbbVie Inc.
  • Astellas Pharma Inc.
  • Pfizer Inc.
  • Remicade group

TYK## inhibition was also highly efficacious in the anti-CD##-induced colitis model in severe combined immunodeficiency (SCID) mice, providing protection against both weight loss and histologically evident colitis, and was as effective as an anti-p## antibody (Gillooly et al., 2016)

  • Immunotherapy
  • Market Size
  • Allergan plc
  • Apricus Biosciences, Inc.
  • Pfizer Inc.

Appetite is often decreased during periods of disease exacerbation, leading to further weight loss.

  • Immunotherapy
  • Market Size
  • AbbVie Inc.
  • AstraZeneca PLC
  • Takeda Pharmaceutical Company Limited

WEIGHT LOSS AND MALNUTRITION ARE COMMON SECONDARY TO DYSPHAGIA, BOTH OF WHICH CONTRIBUTE TO A POORER PATIENT PROGNOSIS.

  • Immunotherapy
  • Biogen Idec Inc.
  • Novartis AG
  • Roche Group
  • Sanofi S.A.

US Key Opinion Leader Adlumiz (anamorelin) is being developed by Helsinn for the treatment of cancer cachexia, anorexia, and unintended weight loss.

  • Immunotherapy
  • United States
  • Amgen Inc.
  • BeyondSpring Pharmaceuticals Inc.
  • Helsinn Group

The BOLERO-## trial results reported that the most common AEs, affecting more than ##% of subjects, in the Afinitor treatment arm were stomatitis, rash, fatigue, diarrhea, nausea, decreased appetite, weight loss, and cough.

  • Immunotherapy
  • Market Size
  • AstraZeneca PLC
  • Genentech, Inc.
  • Novartis AG

However, the effect of weight loss on the general risk of cancer among obese patients has been poorly characterized, as only a small proportion of obese persons are able to achieve sustained weight loss.

  • Immunotherapy
  • Market Size
  • Bristol-Myers Squibb Company
  • Novartis AG
  • Pfizer Inc.